Stericycle stock (US8636671013): Acquired by Waste Management in major healthcare waste deal

Stericycle has been acquired by Waste Management in a $7.2 billion deal, integrating its medical waste services into a larger platform. Recent executive changes at WM highlight integration progress as of May 2026.

Stericycle, a leading provider of medical waste management and compliance services, was acquired by Waste Management in a $7.2 billion transaction completed in 2024. This deal expanded WM's footprint in healthcare waste, a high-margin segment. On May 13, 2026, WM announced executive changes tied to the Stericycle integration, including the promotion of Tara J. Hemmer to COO, according to GuruFocus as of May 13, 2026.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Stericycle, Inc.
• Sector/industry: Waste management and environmental services
• Headquarters/country: United States
• Core markets: North America, healthcare and regulated waste
• Key revenue drivers: Medical waste collection, compliance services
• Home exchange/listing venue: Nasdaq (SRCL)
• Trading currency: USD

Stericycle: core business model

Stericycle provides regulated waste management solutions, primarily to healthcare organizations, pharmacies, and businesses handling medical waste. Services include collection, transportation, treatment, and disposal of biohazardous materials, as well as compliance training and shredding services. Prior to acquisition, the company served over 600,000 customers across North America.

The model relies on recurring contracts with stable demand driven by regulatory requirements under EPA and OSHA standards. Stericycle's network of treatment facilities ensures efficient processing, contributing to operational margins typically above industry averages, according to investor filings.

Main revenue and product drivers for Stericycle

Revenue stems mainly from healthcare waste services (about 70% of total), followed by asset recovery and electronics recycling. Key products include sharps containers, medical waste boxes, and compliance tools. The Stericycle acquisition by WM in June 2024 for $7.2 billion added these streams to WM's portfolio, enhancing cross-selling opportunities in the US market, per Waste Dive as of May 2026.

Growth drivers include rising healthcare waste volumes from aging populations and expanded pharmaceutical returns programs. For US investors, Stericycle's exposure to the $10 billion US medical waste sector offers defensive qualities amid economic cycles.

Industry trends and competitive position

The US waste management industry faces pressures from ESG regulations and circular economy shifts. Stericycle's focus on compliant disposal positions it well against competitors like Clean Harbors. Post-acquisition, WM leverages Stericycle's expertise to capture more of the fragmented healthcare segment.

Why Stericycle matters for US investors

Listed on Nasdaq, Stericycle provides US investors access to essential services tied to healthcare spending, which comprises 18% of US GDP. The WM integration bolsters scale, potentially improving efficiency for long-term holders tracking waste sector consolidation.

Conclusion

The $7.2 billion acquisition by Waste Management has integrated Stericycle into a larger entity, with recent May 2026 executive promotions signaling smooth progress. This positions the combined operations for growth in regulated waste amid steady US healthcare demand. Investors monitor integration outcomes and sector trends for ongoing developments.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.